Nanotherapeutics for Treating Neurodegenerative Disorders
- 1 Edición - 1 de julio de 2026
- Última edición
- Editores: Manish K. Chourasia, Shubhini A. Saraf, Yashwant Pathak, Mohini Chaurasia
- Idioma: Inglés
Nanotherapeutics for Treating Neurodegenerative Disorders is a comprehensive guide to the cutting edge field of nanotherapeutics. This book reviews the complex landscape of… Leer más
Descripción
Descripción
Nanotherapeutics for Treating Neurodegenerative Disorders is a comprehensive guide to the cutting edge field of nanotherapeutics. This book reviews the complex landscape of neurodegenerative disorders, outlining the nuances of treatment strategies and the imperative role of nanotechnology in revolutionizing therapeutic interventions. From explaining the transport mechanisms of the blood–brain barrier to unveiling the therapeutic potential of stem cell-derived nanocarriers, each chapter offers invaluable insights into the diverse array of nanotherapeutic approaches, helping to reshape the landscape of neurological healthcare. This book provides a comprehensive resource for clinicians, researchers, and students in the fields of neurology and nanotherapeutics.
Puntos claves
Puntos claves
• Reviews the complexities of treatment strategies and the transformative role of nanotechnology in reshap ing therapeutic interventions
• Offers a diverse array of insights, providing readers with invaluable knowledge across a spectrum of nano therapeutic approaches
• Provides current updates on advanced target-based nanotherapeutics
• Offers a diverse array of insights, providing readers with invaluable knowledge across a spectrum of nano therapeutic approaches
• Provides current updates on advanced target-based nanotherapeutics
De interès para
De interès para
Researchers in the field of neuroscience and aging biology, pharmacology, pharmaceutics, toxicology and experimental medicines, drug discovery and development
Índice
Índice
1. Concepts, types, and treatment strategies for neurodegenerative disorders
Rafquat Rana,SrishtyJaiswal, Mitali Sethi, Shourya Tripathi, Pallavi Gupta and Manish K. Chourasia
2. Mechanisms of transport across the Blood: Brain Barrier
Nandita G. Das and Sudip K. Das
3. Need for nanotherapeutics to combat neurodegenerative disorders Siddhant Kumar, Sumit Kumar, Rahul Shukla and Shubhini A. Saraf
4. Nanotechnology-mediated drug delivery for addressing protein aggregation
Shourya Tripathi, Srishty Jaiswal, Rafquat Rana, Pooja Yadav, Keerti Mishra, Mitali Sethi and Manish Kumar Chourasia
5. Nano carriers focusing on synuclein misfolding as a therapeutic target
Jayvadan Patel and Komal Parmar
6. Therapeutic potential of stem cells-derived nanocarriers in neurological disorders
Arun Kiritbhai Soni, Mahima Sukhadia, Pratham Shah and Nilay Solanki
7. Emphasizing mitochondrial dysfunction and autophagy in the treatment of neurological disorders Srishty Jaiswal, Shourya Tripathi, Rafquat Rana, Mitali Sethi, Pallavi Gupta and Manish Kumar Chourasia
8. Nanocarrier-assisted delivery of drug(s)/genetic material for the targeted treatment of neurodegenerative disease
Joseph S.D’ Arrigo
9. Nanotherapeutics targeting neuroinflammation
Bivek Chaulagain, Benjamin Tagoe, Avinash Gothwal, Arun Kumar Mahanta, Chinenye Edith Muolokwu, Babita Lamsal and Jagdish Singh
10. Nanocarriers mediated DNA repair mechanism against neurological disorders
Saumyadeep Bora, Mahima Jadav, Hitesh Kulhariand Deep Pooja
11. Nanotherapy for targeted inhibition of protein kinase R-like endoplasmic reticulum kinase: Unraveling stress-induced endoplasmic reticulum kinase
Tolulope Adromola Owolabi, Samson A. Adeyemi and Yahya E. Choonara
12. Nanotechnological and molecular strategies for targeted modulation of microglia in neurodegenerative diseases
Soumil Nema, Aashi Sharma, Sebastian Werneburg, Anita Singh and Yuvraj Singh
13. Nanocarriers unveiling ferroptosis as a potential therapeutic target
Yahya Essop Choonara and Mduduzi N. Sithole
14. Proteostasis maintenance through nanotechnology: Mitigating protein misfolding, mitochondrial impairment, and oxidative stress
Juyoun Janis Park, Grace Kuo, Anika Khandekar, Suha Shin, Lena Wang, Tanisha Taneja and Xiaobo Mao
15. Modulation of Hippo signaling pathway dysregulation through nanotechnology for neurodegenerative disorders
Ramya Buradi, Pallavi Shelke and Awanish Mishra
16. Nanocarriers modulating fibrinolytic pathways for the treatment of various neurological disorders Keerti Mishra, Amrendra K.Tiwari, JVUS Chakradhar, Mitali Sethi, Shivi Nandani Pandey, Rafquat Rana, Shourya Tripathi, Manish K. Chourasia and Mohini Chaurasia
17. Targeting glial cells through nanotherapeutic strategies in neurological disorders
Shubham Kumar Singh, Subhrajyoti Mallick, Harsh Dinodiya, Shubh Baid and Raviraj Vankayala
18. Oligodendrocytes as an emerging therapeutic targets in neurological disorders
Karthikeya Lalitha Siddhartha Pallem, Faizan Md, Khushboo and Umesh Gupta
Rafquat Rana,SrishtyJaiswal, Mitali Sethi, Shourya Tripathi, Pallavi Gupta and Manish K. Chourasia
2. Mechanisms of transport across the Blood: Brain Barrier
Nandita G. Das and Sudip K. Das
3. Need for nanotherapeutics to combat neurodegenerative disorders Siddhant Kumar, Sumit Kumar, Rahul Shukla and Shubhini A. Saraf
4. Nanotechnology-mediated drug delivery for addressing protein aggregation
Shourya Tripathi, Srishty Jaiswal, Rafquat Rana, Pooja Yadav, Keerti Mishra, Mitali Sethi and Manish Kumar Chourasia
5. Nano carriers focusing on synuclein misfolding as a therapeutic target
Jayvadan Patel and Komal Parmar
6. Therapeutic potential of stem cells-derived nanocarriers in neurological disorders
Arun Kiritbhai Soni, Mahima Sukhadia, Pratham Shah and Nilay Solanki
7. Emphasizing mitochondrial dysfunction and autophagy in the treatment of neurological disorders Srishty Jaiswal, Shourya Tripathi, Rafquat Rana, Mitali Sethi, Pallavi Gupta and Manish Kumar Chourasia
8. Nanocarrier-assisted delivery of drug(s)/genetic material for the targeted treatment of neurodegenerative disease
Joseph S.D’ Arrigo
9. Nanotherapeutics targeting neuroinflammation
Bivek Chaulagain, Benjamin Tagoe, Avinash Gothwal, Arun Kumar Mahanta, Chinenye Edith Muolokwu, Babita Lamsal and Jagdish Singh
10. Nanocarriers mediated DNA repair mechanism against neurological disorders
Saumyadeep Bora, Mahima Jadav, Hitesh Kulhariand Deep Pooja
11. Nanotherapy for targeted inhibition of protein kinase R-like endoplasmic reticulum kinase: Unraveling stress-induced endoplasmic reticulum kinase
Tolulope Adromola Owolabi, Samson A. Adeyemi and Yahya E. Choonara
12. Nanotechnological and molecular strategies for targeted modulation of microglia in neurodegenerative diseases
Soumil Nema, Aashi Sharma, Sebastian Werneburg, Anita Singh and Yuvraj Singh
13. Nanocarriers unveiling ferroptosis as a potential therapeutic target
Yahya Essop Choonara and Mduduzi N. Sithole
14. Proteostasis maintenance through nanotechnology: Mitigating protein misfolding, mitochondrial impairment, and oxidative stress
Juyoun Janis Park, Grace Kuo, Anika Khandekar, Suha Shin, Lena Wang, Tanisha Taneja and Xiaobo Mao
15. Modulation of Hippo signaling pathway dysregulation through nanotechnology for neurodegenerative disorders
Ramya Buradi, Pallavi Shelke and Awanish Mishra
16. Nanocarriers modulating fibrinolytic pathways for the treatment of various neurological disorders Keerti Mishra, Amrendra K.Tiwari, JVUS Chakradhar, Mitali Sethi, Shivi Nandani Pandey, Rafquat Rana, Shourya Tripathi, Manish K. Chourasia and Mohini Chaurasia
17. Targeting glial cells through nanotherapeutic strategies in neurological disorders
Shubham Kumar Singh, Subhrajyoti Mallick, Harsh Dinodiya, Shubh Baid and Raviraj Vankayala
18. Oligodendrocytes as an emerging therapeutic targets in neurological disorders
Karthikeya Lalitha Siddhartha Pallem, Faizan Md, Khushboo and Umesh Gupta
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Publicado: 1 de julio de 2026
- Idioma: Inglés
Sobre los editores
Sobre los editores
MC
Manish K. Chourasia
Manish K. Chourasia is the Chief Scientist in the Division of Pharmaceutics and Pharmacokinetics at CSIR Central Drug Research Institute (CDRI), Lucknow, India. He has played a significant role in advancing the field of nanoparticle-based drug delivery for breast cancer and neurodegenerative disorders, aiming to enhance the therapeutic outcome.
Afiliaciones y experiencia
Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, IndiaSS
Shubhini A. Saraf
Shubhini A. Saraf is the Director of the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, Uttar Pradesh, India. Her research interests include nanotechnology and drug targeting as well as technology policy interventions for health care.
Afiliaciones y experiencia
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, Lucknow, Uttar Pradesh, IndiaYP
Yashwant Pathak
Yashwant Pathak is a Professor at Taneja College of Pharmacy at the University of South Florida, FL, United States. His area of research is nanotechnology, drug delivery systems, and nutraceuticals. He is also an Ad junct Professor at the Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.
Afiliaciones y experiencia
College of Pharmacy, University of South Florida, Tampa, FL, USAMC
Mohini Chaurasia
Mohini Chaurasia is a Professor at Era College of Pharmacy, Era University, Lucknow, Uttar Pradesh, India. Her research interests include drug delivery systems and nanotechnology applications in healthcare and biomedical field.
Afiliaciones y experiencia
Faculty of Pharmacy, Era College of Pharmacy, Era University, Lucknow, Uttar Pradesh, India